share_log

Benchmark Reiterates Buy on Nutex Health, Maintains $2.5 Price Target

Benzinga ·  Aug 29, 2023 20:17

Benchmark analyst Bill Sutherland reiterates Nutex Health (NASDAQ:NUTX) with a Buy and maintains $2.5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment